Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial

Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T02:51:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-25T03:00:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T02:45:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T03:29:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry v3.7.0 and removes the previous v3.6.6 entry, updating the version history to reflect the latest documentation update.
    Difference
    0.1%
    Check dated 2026-09-20T01:48:29.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed. This update reflects an adjustment to the version log within the study's history page.
    Difference
    0.1%
    Check dated 2026-08-30T00:32:14.000Z thumbnail image

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.